dicarbethoxydihydrocollidine has been researched along with Cardiomyopathies, Primary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dhanani, M; Head, BP; Kim, KH; Kim, SY; Leem, J; Patel, HH; Roth, DM; Schilling, JM; Zemljic-Harpf, AE | 1 |
Desai, MS; Eblimit, Z; Karpen, SJ; Kosters, A; Moore, DD; Penny, DJ; Thevananther, S | 1 |
2 other study(ies) available for dicarbethoxydihydrocollidine and Cardiomyopathies, Primary
Article | Year |
---|---|
Protective role of cardiac-specific overexpression of caveolin-3 in cirrhotic cardiomyopathy.
Topics: Action Potentials; Animals; Cardiomyopathies; Caveolin 3; Disease Models, Animal; Heart Rate; Isolated Heart Preparation; Liver Cirrhosis, Biliary; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Contraction; Myocardium; Pyridines; Signal Transduction; Time Factors; Up-Regulation | 2020 |
Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis.
Topics: Adrenergic beta-Agonists; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biomarkers; Cardiomyopathies; Cholestasis; Cholic Acid; Disease Models, Animal; Drug Resistance; Liver; Liver Cirrhosis, Biliary; Male; Mice, Inbred C57BL; Mice, Knockout; Pyridines; Recovery of Function; Signal Transduction; Time Factors; Ventricular Function, Left | 2015 |